1. Goonewardene ST, Tang C, Tan LT, Chan KG, Lingham P, Lee LH, Goh BH, Pusparajah P (2019) Safety and efficacy of pneumococcal vaccination in pediatric nephrotic syndrome. Front Pediatr 7:339
2. Uncu N, Bulbul M, Yildiz N, Noyan A, Kosan C, Kavukcu S, Caliskan S, Gunduz Z, Besbas N, Gur Guven A (2010) Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr 169:73–76
3. Vandecasteele SJ, Ombelet S, Blumental S, Peetermans WE (2015) The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J 8:318–324
4. Centers for Disease Control and Prevention (2019) Vaccination coverage for selected diseases by age 24 months, by race and Hispanic origin, poverty level, and location of residence: United States, birth years 2010–2015. https://www.cdc.gov/nchs/data/hus/2019/031-508.pdf. Accessed 27 Sept 2021
5. Nuorti JP, Whitney CG (2010) Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59:1–18